Home » Topics » BioWorld Science

BioWorld Science
RSS

Immtech International achieves several milestones during fourth quarter

July 12, 2001

NDS filed for d-methylphenidate in Canada for ADD and ADHD

July 12, 2001

Beneficial effects reported for T-588 in animal model of ALS

July 12, 2001

Company Profile: Diabetogen

July 12, 2001

Genencor and Epimmune to codevelop vaccines for three oncogenic viruses

July 12, 2001

Human factor VIII-expressing gutless adenovirus vector for hemophilia A

July 12, 2001

Factor VIII retroviral construct safe and potentially effective in hemophilia A patients

July 12, 2001

Blood outgrowth endothelial cell-based gene therapy for hemophilia tested in mice

July 12, 2001

ML-3000 inhibits PMN/platelet interactions in vitro

July 12, 2001

P2T antagonist AR-C69931 acts synergistically with PGE1 to inhibit Ca2+ mobilization in platelets

July 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...